Cargando…

‘No evidence of disease activity’ – is it an appropriate surrogate in multiple sclerosis?

The increasing number of disease‐modifying treatments available for multiple sclerosis has broadened treatment options for patients, but also challenges clinicians to select the best therapy for each individual at the appropriate stage of the disease. Early prediction of treatment response still rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegen, H., Bsteh, G., Berger, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099351/
https://www.ncbi.nlm.nih.gov/pubmed/29687559
http://dx.doi.org/10.1111/ene.13669